Nephrology - European Medical Journal

Continue

Nephrology

Filter
7 Mins
12 Dec 2024

Targeting IgAN with Sparsentan + a SGLT2i

IgA nephropathy (IgAN) can impact life expectancy in those affected, thus efficacious treatment is key. Endothelin 1 (ET-1) and angiotensin…
10 Mins
24 Oct 2024

Advances in proteinuria-targeting therapy in IgAN

Advances in Therapy to Address Proteinuria in Patients with Immunoglobulin A Nephropathy. As the majority of patients with IgA…
7 Mins
23 Aug 2024

Proliferative Lupus Nephritis with Focal Extracapillary Proliferation in Latin America

This study investigates the impact of extracapillary proliferation in proliferative lupus nephritis on remission rates in patients.
6 Mins
24 Jul 2024

Interview: David Wheeler

When I was a junior doctor, I was exposed to a number of different chronic diseases. However, kidney disease fascinated me the most…
5 Mins
4 Jul 2024

Immune Complex-mediated MPGN Secondary to Primary Biliary Cholangitis

Immune complex-mediated membranoproliferative glomerulonephritis (iMPGN) can develop in association with autoimmune diseases such as…
8 Mins
4 Jul 2024

Characteristics, Humanistic Burden, and Kidney Outcomes in Immunoglobulin A Nephropathy

IgAN is an immune-complex mediated glomerular disease with an incidence rate of 0.03−10.5/100,000 persons/year…
12 Mins
4 Jul 2024

Challenges in Renal Replacement Therapy in Resource-Limited Settings

Chronic kidney disease (CKD) continues to be a global public health problem. Globally, the prevalence of CKD is approximately 8–16% in the…
12 Mins
4 Jul 2024

End-Stage Renal Disease and Neurological Connection

Due to the incapacitating nature of end-stage renal disease, people on dialysis frequently acquire undetected psychopathological disorders.